Insights into the role of DNA methylation in immune cell development and autoimmune disease
J Li, L Li, Y Wang, G Huang, X Li, Z Xie… - Frontiers in Cell and …, 2021 - frontiersin.org
J Li, L Li, Y Wang, G Huang, X Li, Z Xie, Z Zhou
Frontiers in Cell and Developmental Biology, 2021•frontiersin.orgTo date, nearly 100 autoimmune diseases have been an area of focus, and these diseases
bring health challenges to approximately 5% of the population worldwide. As a type of
disease caused by tolerance breakdown, both environmental and genetic risk factors
contribute to autoimmune disease development. However, in most cases, there are still gaps
in our understanding of disease pathogenesis, diagnosis, and treatment. Therefore, more
detailed knowledge of disease pathogenesis and potential therapies is indispensable. DNA …
bring health challenges to approximately 5% of the population worldwide. As a type of
disease caused by tolerance breakdown, both environmental and genetic risk factors
contribute to autoimmune disease development. However, in most cases, there are still gaps
in our understanding of disease pathogenesis, diagnosis, and treatment. Therefore, more
detailed knowledge of disease pathogenesis and potential therapies is indispensable. DNA …
To date, nearly 100 autoimmune diseases have been an area of focus, and these diseases bring health challenges to approximately 5% of the population worldwide. As a type of disease caused by tolerance breakdown, both environmental and genetic risk factors contribute to autoimmune disease development. However, in most cases, there are still gaps in our understanding of disease pathogenesis, diagnosis, and treatment. Therefore, more detailed knowledge of disease pathogenesis and potential therapies is indispensable. DNA methylation, which does not affect the DNA sequence, is one of the key epigenetic silencing mechanisms and has been indicated to play a key role in gene expression regulation and to participate in the development of certain autoimmune diseases. Potential epigenetic regulation via DNA methylation has garnered more attention as a disease biomarker in recent years. In this review, we clarify the basic function and distribution of DNA methylation, evaluate its effects on gene expression and discuss related key enzymes. In addition, we summarize recent aberrant DNA methylation modifications identified in the most important cell types related to several autoimmune diseases and then provide potential directions for better diagnosing and monitoring disease progression driven by epigenetic control, which may broaden our understanding and contribute to further epigenetic research in autoimmune diseases.
![](/scholar/images/qa_favicons/frontiersin.org.png)